Teja Ganta

Statistics

Publications

Citations

205

H-Index

Active since

2015

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Teja Ganta is an author at Icahn School of Medicine at Mount Sinai specializing in oncology, immunotherapy safety, and messenger rna binding proteins.

ORCID

Publications per year

2015–2024

Publications

Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer

Caroline A. Nebhan, Alessio Cortellini, Weijie Ma et al. · JAMA Oncology · 2021 · 152 citations · Full text

Medicine, Immunology, Oncology +17

The RNA‐binding protein Musashi 1 stabilizes the oncotachykinin 1 mRNA in breast cancer cells to promote cell growth

George Nahas, Raghav G. Murthy, Shyam A. Patel et al. · The FASEB Journal · 2015 · 30 citations

Life Sciences, Molecular Biology, Oncology +17

Fairness in Predicting Cancer Mortality Across Racial Subgroups

Teja Ganta, Arash Kia, Prathamesh Parchure et al. · JAMA Network Open · 2024 · 13 citations · Full text

Medicine, Health Informatics, Oncology +17

Patient portal access for caregivers of adult and geriatric patients: reframing the ethics of digital patient communication

Teja Ganta, Jacob M. Appel, Nicholas Genes · Journal of Medical Ethics · 2022 · 10 citations

Health Professions, Health Informatics, Health Law +17

1–4 of 4